Hospital Charles Nicolle, Tunis Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2011
NCT01354704
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Hospital Charle Nicolle | Hospital Charles Nicolle | Hospital Charles Nicolle Tunis. | Hospital Charles Nicollle

Active Ingredients

Drugs in Phase 4 Trials (1)

enoxaparin (lovenox) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Thrombosis (Phase 4)

Venous Thrombosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1